Reference
1. Leo S D, Lee S Y and Braverman L E, Hyperthyroidism, Lancet, vol. 388, no. 10047, pp. 906–918, 2016
2. Biondi B, Heart failure and thyroid dysfunction, European Journal of Endocrinology (2012) 167 609–618 2012
3. MALIK R, and HODGSON H, The relationship between the thyroid gland and the liver Q J Med 2002; 95:559–569
4. Brent G. The molecular basis of thyroid hormone action. N Engl J Med. 1994;331:847– 853.
5. Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinologica. 2004;29:139 –150
6. Resnick LM, Laragh JH. Plasma renin activity in syndromes of thyroid hormone excess and
deficiency. Life Sci 1982; 30: 585-6.
7. Biondi B, Palmieri E A, Lombardi G, et al, Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 2002,
8. Brandt F, Green A, Hegedüs L, et al A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol 2011; 165: 491-7.
9.Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998;27:51-62.
10.Klein I, Danzi S: Thyroid disease and the heart. Circulation 2007, 116:1725. ttp://dx.doi.org/10.1161/CIRCULATIONAHA.106.678326.
11. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke 1988; 19: 15-8.
12. Akamizu T, Satoh T, Isozaki O, et al. (2012) Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid 22: 661-679.
13. Satoh T, Isozaki O, Suzuki A, et al 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition)
14. Staffurt J S, Gibberd J S, Tang FS: Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977, 2:688-690
15. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994 Nov 10;331(19):1249-52.
16.Bartalena L, Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 2013; 9: 724–734.
17.Thurnheer R, Jenni R, Russi EW, et al. Hyperthyroidism and pulmonary hypertension. J Intern Med 1997;242:185-8.
18.Eleftheraidis D, Fourlas E. Eleftheriadis, N, Hidden hyperthyroidism in a young male patient. Int J Cardiol 2003 Jun;89(2-3):313-4
19. Holmes S. J, Espiner E. A, Richards A M, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J. Clin. Endocrinol. Metab. 1993, 76, 91–96.
20. Myers J D, Brannon E S, Holland B C. A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest1950; 29(8): 1069–1077.
21. Pasyechko N V, Kuleshko I I, Kulchinska V M. et al. Ultrastructural liver changes in the experimental thyrotoxicosis, Pol J Pathol 2017; 68 (2): 144-147
22 Alvarez A M, Mukherjee D, Liver Abnormalities in Cardiac Diseases and Heart Failure. Int J Angiol 2011;20:135–142.